The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Alere Inc

NYSE: ALR
Last

(U.S.) $38.40

Today's change0.00 0.00%
Updated December 19 4:02 PM EST. Delayed by at least 15 minutes.
 

Alere Inc

NYSE: ALR
Last

(U.S.) $38.40

Today's change0.00 0.00%
Updated December 19 4:02 PM EST. Delayed by at least 15 minutes.

Alere Inc closed at (U.S.)$38.40.

Over the last five days, shares have gained 5.73% and 6.08% year to date. Shares have underperformed the S&P 500 by 7.73% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $38.40
  • High--
  • Low--
  • Bid / Ask-- / --
  • YTD % change+6.08%
  • Volume0
  • Average volume (10-day)530,216
  • Average volume (1-month)457,553
  • Average volume (3-month)516,283
  • 52-week range(U.S.) $31.94 to (U.S.) $43.00
  • Beta1.92
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward17.63×
  • Forward PEG1.76×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$2.04
Updated December 19 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-5.59%

Alere Inc has a net profit margin of -5.59%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.85%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue736738717772
Total other revenue--------
Total revenue736738717772
Gross profit349340351384
Total cost of revenue388398365388
Total operating expense699747691733
Selling / general / administrative260298280299
Research & development33343938
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)181767
Other operating expenses, total--------
Operating income37-92639
Interest income (expense), net non-operating-52-52-52-52
Gain (loss) on sale of assets--------
Other--------
Income before tax-23-58-21-18
Income after tax-100-52-11-8
Income tax, total77-7-10-10
Net income-86-50-6-4
Total adjustments to net income-5-5-5-5
Net income before extra. items-93-50-6-4
Minority interest0000
Equity in affiliates6254
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-99-55-11-9
Inc. avail. to common incl. extra. items-92-55-11-9
Diluted net income-92-55-11-9
Dilution adjustment0000
Diluted weighted average shares83838282
Diluted EPS excluding extraordinary itemsvalue per share-1.19-0.67-0.14-0.11
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-1.05-0.53-0.05-0.09